Session I, Part I
Moderator: Jacqui Hecht, University of Texas, Houston
The Nosology of Rare Bone Diseases based upon their clinical, radiographic, histologic, biochemical and molecular characteristics
- Deborah Krakow, University of California, Los Angeles
Osteoblast and osteocyte biology - Lynda Bonewald, University of Missouri, Kansas City
Osteoclast biology - Stuart Ralston, University of Edinburg, United Kingdom
Session I, Part II
Moderator: Henry Kronenberg, Massachusetts General Hospital, Boston
Chondrocyte biology - Maurizio Pacifici, Children’s Hospital of Pennsylvania
Vascular biology - Bjorn Olsen, Harvard University
Matrix Biology - Brendan Lee, Baylor College of Medicine
Lunch/Keynote Lecture
Coupling knock in mice with massively parallel sequencing to unravel the role of Runx2 in transcriptional regulation of bone cell
differentiation and function - Andy McMahon
University of Southern California
Session II, Part I
Moderator: Christopher Niyibizi, Pennsylvania State University, Harrisburg
Treating osteoclast over-activity with bisphosphonates and interferon - Graham Russell, University of Oxford
Treating Hypophosphatasia by targeting enzyme replacement therapy to bone - Michael Whyte, Shriners Hospital, St. Louis
Treating skeletal fragility by antibody based inhibition of Wnt or TGFb antagonists - Matthew Warman, Boston Children’s
Hospital
Session II, Part II
Moderator: Laura Tosi, Children’s National Medical Center
Small molecule inhibitors of the mTor signaling pathway - Denise Adams, Cincinnati Children’s Hospital
Promotion of skeletal anabolism using synthetic polypeptides - Laurence Legeai-Mallet, INSERM, Paris
Moderator: Jacqui Hecht, University of Texas, Houston
The Nosology of Rare Bone Diseases based upon their clinical, radiographic, histologic, biochemical and molecular characteristics
- Deborah Krakow, University of California, Los Angeles
Osteoblast and osteocyte biology - Lynda Bonewald, University of Missouri, Kansas City
Osteoclast biology - Stuart Ralston, University of Edinburg, United Kingdom
Session I, Part II
Moderator: Henry Kronenberg, Massachusetts General Hospital, Boston
Chondrocyte biology - Maurizio Pacifici, Children’s Hospital of Pennsylvania
Vascular biology - Bjorn Olsen, Harvard University
Matrix Biology - Brendan Lee, Baylor College of Medicine
Lunch/Keynote Lecture
Coupling knock in mice with massively parallel sequencing to unravel the role of Runx2 in transcriptional regulation of bone cell
differentiation and function - Andy McMahon
University of Southern California
Session II, Part I
Moderator: Christopher Niyibizi, Pennsylvania State University, Harrisburg
Treating osteoclast over-activity with bisphosphonates and interferon - Graham Russell, University of Oxford
Treating Hypophosphatasia by targeting enzyme replacement therapy to bone - Michael Whyte, Shriners Hospital, St. Louis
Treating skeletal fragility by antibody based inhibition of Wnt or TGFb antagonists - Matthew Warman, Boston Children’s
Hospital
Session II, Part II
Moderator: Laura Tosi, Children’s National Medical Center
Small molecule inhibitors of the mTor signaling pathway - Denise Adams, Cincinnati Children’s Hospital
Promotion of skeletal anabolism using synthetic polypeptides - Laurence Legeai-Mallet, INSERM, Paris
| Agenda and poster presentation abstract submission Page |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||
| Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study of Rare Bone Diseases Thursday, September 11th, 2014 (One day prior to the ASBMR 2014 Annual Meeting) To have your abstract considered for a poster presentation at the National Bone Health Alliance/Rare Bone Disease Patient Network Workshop: Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study of Rare Bone Diseases, in addition to the ASBMR 2014 Annual Meeting presentations, select the box indicating your willingness in the “Scientific Information” section of the ASBMR Abstract Center. The Abstract Submission Deadline for the ASBMR 2014 Annual Meeting is Wednesday, April 9, 2014, 5:00 p.m., Eastern Daylight Time (EDT). In addition Up to 20 Young Investigator Travel Grants of $500 each will be given to individuals who are selected to present their abstract. |
Written consent must be obtained to attach web pages or the files attached to this website, please email the webmaster. Email the webmaster: webmaster@mheresearchfoundation.org Materials on this website are protected by copyright Copyright © 2014 The MHE Research Foundation Disclaimer: While many find the information useful, it is in no way a substitute for professional medical care. The information provided here is for educational and informational purposes only. This website does not engage in the practice of medicine. In all cases we recommend that you consult your own physician regarding any course of treatment or medicine. This web page was updated last on 3/16/14, 12:0O pm Eastern time |
The MHE Research Foundation, we comply with the HONcode standard for health trust worthy information: By the Health On the Net Foundation.
Click here to verify.# HON Conduct 282463 and is the patient support link on the US Government Genetics Home Reference (http://ghr.nlm.nih.gov)
website, also linked for Patient Information on The Diseases Database a cross-referenced index of human disease, as well as the
Intute: health & life sciences a free online service providing access to the very best Web resources for education and research located in the UK
Click here to verify.# HON Conduct 282463 and is the patient support link on the US Government Genetics Home Reference (http://ghr.nlm.nih.gov)
website, also linked for Patient Information on The Diseases Database a cross-referenced index of human disease, as well as the
Intute: health & life sciences a free online service providing access to the very best Web resources for education and research located in the UK
| This website is regularly reviewed by members of the Scientific and Medical Advisory Board of the MHE Research Foundation. All online submission forms use (SSL AES 256 bit encryption (High); RSA 1024 bit exchange) Protocol with Privacy protection. Our goal is to make this website as safe and user friendly as possible. |
| The MHE Research Foundation is a participating member organization of the United States Bone and Joint Decade/Initiative, (USBJD/I) & the USBJD/I Rare Bone Disease Patient Network NBHA National Bone Health Alliance |
The MHE Research Foundation is proud to be an affiliate of the Society For Glycobiology
